1 Min Read
June 7 (Reuters) - Roche Holding AG:
* FDA APPROVES GENENTECH’S RITUXAN (RITUXIMAB) FOR PEMPHIGUS VULGARIS
* GENENTECH- RITUXAN IS NOW FDA-APPROVED TO TREAT FOUR AUTOIMMUNE DISEASES Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.